SCHEMBL2860232

SCHEMBL2860232

CC1OC(=O)[C@@H](C)OC1=O

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TAS2R46 P59540 2/20 0.31
MAOA P21397 1/20 0.30
PARP1 P09874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8104271 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL44996 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL439067 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL682255 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL732959 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL15034 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL15195848 1.00 CA1 (0.41) CA1CA9SMN1; SMN2MEN1KMT2A
Methane SCHEMBL1276943 0.96 CA1 (0.39) CA1CA9SMN1; SMN2MEN1KMT2A
SCHEMBL2314693 0.96 CA1 (0.39) CA1CA9SMN1; SMN2MEN1KMT2A
Ammonia Solution, Strong SCHEMBL17351919 0.96 CA1 (0.39) CA1CA9SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220235176-A1 METHOD FOR PRODUCING POLYETHER ESTER CARBONATE POLYOLS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-07-28 US claimed
EP-3994198-A1 METHOD FOR PRODUCING POLYETHER ESTER CARBONATE POLYOLS Covestro Intellectual Property GmbH & Co. KG (DE) 2022-05-11 EP claimed
CN-114026148-A Method for producing polyether ester carbonate polyols 科思创知识产权两合公司 2022-02-08 CN claimed
WO-2021004814-A1 METHOD FOR PRODUCING POLYETHER ESTER CARBONATE POLYOLS COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2021-01-14 WO claimed
EP-3760663-A1 METHOD FOR MANUFACTURING POLYETHER ESTER CARBONATE POLYOLS Covestro Deutschland AG (DE) 2021-01-06 EP claimed
US-20260074195-A1 COMPOSITION, ANODE AND BATTERY LARGAN MEDICAL CO LTD (TW) 2026-03-12 US disclosed
EP-4700844-A1 ANODE COMPOSITION, ANODE AND BATTERY Largan Precision Co. Ltd. (TW) 2026-02-25 EP disclosed
EP-4636839-A2 COMPOSITION, ANODE AND BATTERY Largan Precision Co. Ltd. (TW) 2025-10-22 EP disclosed
US-20250309250-A1 COMPOSITION, ANODE AND BATTERY LARGAN PRECISION CO., LTD. (TW) 2025-10-02 US disclosed
US-12338197-B2 Process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid UNIVERZITA PARDUBICE (CZ) 2025-06-24 US disclosed
EP-4517876-A1 COMPOSITION, ANODE AND BATTERY Largan Medical Co., Ltd. (TW) 2025-03-05 EP disclosed
US-20240352187-A1 POLYMER, ELECTROLYTE AND BATTERY LARGAN MEDICAL CO., LTD. (TW) 2024-10-24 US disclosed
US-20170066853-A1 FLUORO-ALCOHOL ADDITIVES FOR ORIENTATION CONTROL OF BLOCK COPOLYMERS INTERNATIONAL BUSINESS MACHINES CORPORATION 2017-03-09 US disclosed
US-20170022320-A1 LACTIDE POLYMERISATION SCG CHEMICALS CO., LTD. (TH) 2017-01-26 US disclosed
US-20170022320-A1 LACTIDE POLYMERISATION SCG CHEMICALS CO., LTD. (TH) 2017-01-26 US disclosed
US-20100255098-A1 STEREOCOMPLEX HYDROGELS UNIVERSITEIT UTRECHT (NL) 2010-10-07 US disclosed
US-7776359-B1 Stereocomplex hydrogels UNIVERSITEIT UTRECHT (NL) 2010-08-17 US disclosed
US-20090198038-A1 Novel Catalysts for the Polymerisation of Carbonyl-Containing or Cyclic Monomers THE UNIVERSITY OF NOTTINGHAM (GB) 2009-08-06 US disclosed
US-20080058954-A1 Methods of treating spinal injuries using injectable flowable compositions comprising organic materials WARSAW ORTHOPEDIC, INC. 2008-03-06 US disclosed
EP-1183016-B1 STEREOCOMPLEX HYDROGELS UNIV UTRECHT (NL) 2004-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090198038-A1 Novel Catalysts for the Polymerisation of Carbonyl-Containing or Cyclic Monomers LDHA, ME3, CBR3 CA1 18/4885CA9 39/4885SMN1; SMN2 3956/4885
US-20170022320-A1 LACTIDE POLYMERISATION MALT1, MLX, LAS1L CA1 1094/4885CA9 2239/4885SMN1; SMN2 3147/4885
US-20260074195-A1 COMPOSITION, ANODE AND BATTERY SCN10A, SAMM50, SOD1 CA1 208/4885CA9 448/4885SMN1; SMN2 237/4885
US-12338197-B2 Process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid HRH2, LDHA, HCAR2 CA1 100/4885CA9 205/4885SMN1; SMN2 4400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.